Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00893984 · ClinicalTrials.gov registry record · Phase 4
Alternative in Beta Blocker Intolerance: The ABBI Trial
A Phase 4 study, sponsored by Minneapolis Heart Institute Foundation.
- Terminated
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT00893984: Clinical Trial Phase 4 study, sponsored by Minneapolis Heart Institute Foundation.
NCT00893984 is a Phase 4 study that was terminated before completion, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 6 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00893984, a Phase 4 study, was terminated before completion, sponsored by Minneapolis Heart Institute Foundation.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
In this study the investigators will assess the tolerance of Nebivolol (Bystolic) in cardiovascular patients who are not able to tolerate conventional beta blockers. A side effect profile will be tracked and compared with previous beta blocker use. The investigators hypothesize that Bystolic will be tolerated by many patients who are intolerant of conventional blockers.
Interventions
- DRUG Nebivolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-06 |
| Phase | Phase 4 |
Why NCT00893984 stopped before completion
NCT00893984 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Nebivolol is the first listed.
NCT00893984 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00893984 about?
NCT00893984 is a clinical study titled "Alternative in Beta Blocker Intolerance: The ABBI Trial". In this study the investigators will assess the tolerance of Nebivolol (Bystolic) in cardiovascular patients who are not able to tolerate conventional beta blockers. A side effect profile will be tracked and compared with previous beta blocker use. The investigators hypothesize that Bystolic will b...
What is the current status of trial NCT00893984?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2009-05. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00893984?
The interventions under investigation include: Nebivolol (DRUG).
Who is sponsoring clinical trial NCT00893984?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00893984's enrollment target sits among peer trials
6 1983rd of 2000 higher than 12 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia